HIV-1 integrase pharmacophore: Discovery of inhibitors through three- dimensional database searching

Journal of Medicinal Chemistry

Volumn 40, Issue 6, 1997, Pages 920-929

  Nicklaus, Marc C ^a   Neamati, Nouri ^a   Hong, Huixiao ^a   Mazumder, Abhijit ^a   Sunder, Sanjay ^a   Chen, Julie ^a   Milne, George W A ^a   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID; DRUG CARRIER; ENZYME INHIBITOR; HYBRID PROTEIN; INTEGRASE; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CALCULATION; CATALYSIS; DATA ANALYSIS; DATA BASE; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; VIRUS REPLICATION;

EID: 0030891601     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960596u     Document Type: Article

References (67)

1. Rice, P.; Craigie, R.; Davies, D. R. Retroviral integrases and their cousins. Curr. Opin. Struct. Biol. 1996, 6, 76-83.
2. Katz, R. A.; Skalka, A. M. The retroviral enzymes. Annu. Rev. Biochem. 1994, 63, 133-173.
3. Vink, C.; Plasterk, R. H. A. The human immunodeficiency virus integrase protein. Trends Genet. 1993, 9, 433-438.
4. Carteau, S.; Mouscadet, J. F.; Goulaouic, H.; Subra, F.; Auclair, C. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. Arch. Biochem. Biophys. 1993, 305, 606-610.
5. Carteau, S.; Mouscadet, J. F.; Goulaouic, H.; Subra, F.; Auclair, C. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction. Biochem. Biophys. Res. Commun. 1993, 192, 1409-1414.
6. Carteau, S.; Mouscadet, J. F.; Goulaouic, H.; Subra, F.; Auclair, C. Inhibition of the in vitro integration of Moloney murine leukemia virus DNA by the DNA minor groove binder netropsin. Biochem. Pharmacol. 1994, 47, 1821-1826.
7. Fesen, M. R.; Kohn, K. W.; Leteurtre, F.; Pommier, Y. Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 2399-2403.
8. Cushman, M.; Sherman, P. Inhibition of HPV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem. Biophys. Res. Commun. 1992, 185, 85-90.
9. Fesen, M. R.; Pommier, Y.; Leteurtre, F.; Hiroguchi, S.; Yung, J.; Kohn, K. W. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 1994, 48, 595-608.
10. Mazumder, A.; Cooney, D.; Agbaria, R.; Gupta, M.; Pommier, Y. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidylate. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 5771-5775.
11. Mazumder, A.; Raghavan, K.; Weinstein, J.; Kohn, K. W.; Pommier, Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem. Pharmacol. 1995, 49, 1165-1170.
12. Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, D. S.; Rabinovitz, M.; Pommier, Y. Inhibition of Human Immunodeficiency Virus Type 1 Integrase by a Hydrophobic Cation: The Phenanthroline-Cuprous Complex. AIDS Res. Hum. Retrovir. 1995, 11, 115-125.
13. Mazumder, A.; Neamati, N.; Sommadossi, J. P.; Gosselin, G.; Schinazi, R. F.; Imbach, J. L.; Pommier, Y. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase. Mol. Pharmacol. 1996, 49, 621-628.
14. Dyda, F.; Hickman, A. B.; Jenkins, T. M.; Engelman, A.; Craigie, R.; Davies, D. R. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 1994, 266, 1981-1986.
15. Bujacz, G.; Jaskólski, M.; Alexandratos, J.; Wlodawer, A.; Merkel, G.; Katz, R. A.; Skalka, A. M. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 1995, 253, 333-346.
16. Bujacz, G.; Jaskólski, M.; Alexandratos, J.; Wlodawer, A.; Merkel, G.; Katz, R. A.; Skalka, A. M. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure 1996, 4, 89-96.
17. Milne, G. W. A.; Wang, S.; Nicklaus, M. C. Molecular Modeling in the Discovery of Drug Leads. J. Chem. Inf. Comput. Sci. 1996, 36, 726-730.
18. Wang, S.; Milne, G. W. A.; Yan, X.; Posey, I. J.; Nicklaus, M. C.; Graham, L.; Rice, W. G. Discovery of Novel, Nonpeptide HIV-1 Protease Inhibitors by Pharmacophore Searching. J. Med. Chem. 1996, 39, 2047-2054.
19. (19) Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 1. System Overview. J. Chem. Inf. Comput. Sci. 1986, 26, 154-159. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P.; Hammel, M. J. The NCI Drug Information System. 2. DIS Pre-Registry. J. Chem. Inf. Comput. Sci. 1986, 26, 159-168. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P. The NCI Drug Information System. 3. The DIS Chemistry Module. J. Chem. Inf. Comput. Sci. 1986, 26, 168-179. Milne, G. W. A.; Miller, J. A.; Hoover, J. R. The NCI Drug Information System. 4. Inventory and Shipping Modules. J. Chem. Inf. Comput. Sci. 1986, 26, 179-185. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 5. DIS Biology Module. J. Chem. Inf. Comput. Sci. 1986, 26, 186-193. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A.; Hammel, M. J. The NCI Drug Information System. 6. System Maintenance. J. Chem. Inf. Comput. Sci. 1986, 26, 193-197.
20. Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 1. System Overview. J. Chem. Inf. Comput. Sci. 1986, 26, 154-159. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P.; Hammel, M. J. The NCI Drug Information System. 2. DIS Pre-Registry. J. Chem. Inf. Comput. Sci. 1986, 26, 159-168. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P. The NCI Drug Information System. 3. The DIS Chemistry Module. J. Chem. Inf. Comput. Sci. 1986, 26, 168-179. Milne, G. W. A.; Miller, J. A.; Hoover, J. R. The NCI Drug Information System. 4. Inventory and Shipping Modules. J. Chem. Inf. Comput. Sci. 1986, 26, 179-185. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 5. DIS Biology Module. J. Chem. Inf. Comput. Sci. 1986, 26, 186-193. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A.; Hammel, M. J. The NCI Drug Information System. 6. System Maintenance. J. Chem. Inf. Comput. Sci. 1986, 26, 193-197.
21. Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 1. System Overview. J. Chem. Inf. Comput. Sci. 1986, 26, 154-159. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P.; Hammel, M. J. The NCI Drug Information System. 2. DIS Pre-Registry. J. Chem. Inf. Comput. Sci. 1986, 26, 159-168. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P. The NCI Drug Information System. 3. The DIS Chemistry Module. J. Chem. Inf. Comput. Sci. 1986, 26, 168-179. Milne, G. W. A.; Miller, J. A.; Hoover, J. R. The NCI Drug Information System. 4. Inventory and Shipping Modules. J. Chem. Inf. Comput. Sci. 1986, 26, 179-185. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 5. DIS Biology Module. J. Chem. Inf. Comput. Sci. 1986, 26, 186-193. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A.; Hammel, M. J. The NCI Drug Information System. 6. System Maintenance. J. Chem. Inf. Comput. Sci. 1986, 26, 193-197.
22. Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 1. System Overview. J. Chem. Inf. Comput. Sci. 1986, 26, 154-159. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P.; Hammel, M. J. The NCI Drug Information System. 2. DIS Pre-Registry. J. Chem. Inf. Comput. Sci. 1986, 26, 159-168. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P. The NCI Drug Information System. 3. The DIS Chemistry Module. J. Chem. Inf. Comput. Sci. 1986, 26, 168-179. Milne, G. W. A.; Miller, J. A.; Hoover, J. R. The NCI Drug Information System. 4. Inventory and Shipping Modules. J. Chem. Inf. Comput. Sci. 1986, 26, 179-185. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 5. DIS Biology Module. J. Chem. Inf. Comput. Sci. 1986, 26, 186-193. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A.; Hammel, M. J. The NCI Drug Information System. 6. System Maintenance. J. Chem. Inf. Comput. Sci. 1986, 26, 193-197.
23. Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 1. System Overview. J. Chem. Inf. Comput. Sci. 1986, 26, 154-159. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P.; Hammel, M. J. The NCI Drug Information System. 2. DIS Pre-Registry. J. Chem. Inf. Comput. Sci. 1986, 26, 159-168. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P. The NCI Drug Information System. 3. The DIS Chemistry Module. J. Chem. Inf. Comput. Sci. 1986, 26, 168-179. Milne, G. W. A.; Miller, J. A.; Hoover, J. R. The NCI Drug Information System. 4. Inventory and Shipping Modules. J. Chem. Inf. Comput. Sci. 1986, 26, 179-185. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 5. DIS Biology Module. J. Chem. Inf. Comput. Sci. 1986, 26, 186-193. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A.; Hammel, M. J. The NCI Drug Information System. 6. System Maintenance. J. Chem. Inf. Comput. Sci. 1986, 26, 193-197.
24. Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 1. System Overview. J. Chem. Inf. Comput. Sci. 1986, 26, 154-159. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P.; Hammel, M. J. The NCI Drug Information System. 2. DIS Pre-Registry. J. Chem. Inf. Comput. Sci. 1986, 26, 159-168. Milne, G. W. A.; Feldman, A.; Miller, J. A.; Daly, G. P. The NCI Drug Information System. 3. The DIS Chemistry Module. J. Chem. Inf. Comput. Sci. 1986, 26, 168-179. Milne, G. W. A.; Miller, J. A.; Hoover, J. R. The NCI Drug Information System. 4. Inventory and Shipping Modules. J. Chem. Inf. Comput. Sci. 1986, 26, 179-185. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A. The NCI Drug Information System. 5. DIS Biology Module. J. Chem. Inf. Comput. Sci. 1986, 26, 186-193. Zehnacker, M. T.; Brennan, R. H.; Milne, G. W. A.; Miller, J. A.; Hammel, M. J. The NCI Drug Information System. 6. System Maintenance. J. Chem. Inf. Comput. Sci. 1986, 26, 193-197.
25. Milne, G. W. A.; Nicklaus, M. C.; Driscoll, J. S.; Wang, S.; Zaharevitz, D. National Cancer Institute Drug Information System 3D Database. J. Chem. Inf. Comput. Sci. 1994, 34, 1219-1224.
26. Wang, S.; Zaharevitz, D.; Sharma, R.; Marquez, V. E.; Lewin, N. E.; Du, L.; Blumberg, P. M.; Milne, G. W. A. The Discovery of Novel, Structurally Diverse Protein Kinase C Agonists through Computer 3-D Database Search. Molecular Modeling Studies. J. Med. Chem. 1994, 37, 4479-4489. (The pharmacophore in 2 that is relevant in the PK-C assay is different from the one assumed to be responsible for potency of the same compound in the IN assay.)
27. Grunberger, D.; Banerjee, R.; Eisinger, K.; Oltz, E. M.; Efros, L.; Caldwell, M.; Estevez, V.; Nakanishi, K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988, 44, 230-232.
28. QUANTA is provided by Molecular Simulations, Inc., 9685 Scranton Rd, San Diego, CA 92121-3752.
29. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMm: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. J. Comput. Chem. 1983, 4, 187-217.
30. Murrall, N. W.; Davies, E. K. Conformational Freedom in 3-D Databases. 1. Techniques. J. Chem. Inf. Comput. Sci. 1990, 30, 312-316.
31. Burke, T. R., Jr.; Fesen, M. R.; Mazumder, A.; Wang, J.; Carothers, A. M.; Grunberger, D.; Driscoll, J.; Kohn, K.; Pommier, Y. Hydroxylated aromatic inhibitors of HIV-1 integrase. J. Med. Chem. 1995, 38, 4171-4178.
32. Cushman, M.; Golebiewski, W. M.; Pommier, Y.; Mazumder, A.; Reymen, D.; De Clercq, E.; Graham, L.; Rice, W. G. Cosalane Analogues with Enhanced Potencies as Inhibitors of HIV-1 Protease and Integrase. J. Med. Chem. 1995, 38, 443-452.
33. LaFemina, R. L.; Graham, P. L.; LeGrow, K.; Hastings, J. C.; Wolfe, A.; Young, S. D.; Emini, E. A.; Hazuda, D. J. Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. 1995, 39, 320-324.
34. Eich, E.; Pertz, H.; Kaloga, M.; Schulz, J.; Fesen, M. R.; Mazumder, A.; Pommier, Y. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J. Med. Chem. 1996, 39, 86-95.
35. Neamati, N.; Mazumder, A.; Sunder, S.; Pommier, Y. Diaryl-sulfones, a Novel Class of HIV-1 Integrase Inhibitors. Proceedings of the 96th General Meeting of the American Society of Microbiology, May 19-23, 1996, New Orleans, LA; Abstract No. T-21, p 584.
36. Mazumder, A.; Wang, S.; Neamati, N.; Nicklaus, M. C.; Sunder, S.; Chen, J.; Milne, G. W. A.; Rice, W. G.; Burke, T. R., Jr.; Pommier, Y. Antiretroviral Agents as Inhibitors of both Human Immunodeficiency Virus Type 1 Integrase and Protease. J. Med. Chem. 1996, 39, 2472-2481.
37. Zhao, H.; Neamati, N.; Hong, H.; Mazumder, A.; Wang, S.; Sunder, S.; Milne, G. W. A.; Pommier, Y.; Burke, T. R., Jr. Coumarin-Based Inhibitors of HIV Integrase. J. Med. Chem. 1997, 40, 242-249.
38. Zhao, H.; Neamati, N.; Mazumder, A.; Sunder, S.; Pommier, Y.; Burke, T. R., Jr. Arylamide Inhibitors of HIV-1 Integrase. J. Med. Chem., in press.
39. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R.; Keith, T.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Cioslowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres, J. L.; Replogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Stewart, J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. Gaussian 94, Rev. C.3; by Gaussian, Inc., Carnegie Office Park, Bldg 6, Pittsburgh, PA 15106.
40. Kearney, P. C.; Mizoue, L. S.; Kumpf, R. A.; Forman, J. E.; McCurdy, A.; Dougherty, D. A. Molecular Recognition in Aqueous Media. New Binding Studies Provide Further Insights into the Cation-π Interaction and Related Phenomena. J. Am. Chem. Soc. 1993, 115, 9907-9919.
41. Yan, X.; Wang, S.; Hodošček, M.; Milne, G. W. A. Prediction of geometries and interaction energies of complexes formed by small molecules using semiempirical and ab initio methods. J. Mol. Struct. 1994, 309, 279-294.
42. Hong, H.; Neamati, N.; Wang, S.; Nicklaus, M. C.; Mazumder, A.; Zhao, H.; Burke, T. R., Jr.; Pommier, Y.; Milne, G. W. A. Discovery of Human Immunodeficiency Virus Type 1 Integrase Inhibitors by Pharmacophore Searching. J. Med. Chem. 1997, 40, 930-936.
43. Clanton, D. J.; Moran, R. A.; McMahon, J. B.; Weislow, O. S.; Buckheit, R. W., Jr.; Hollingshead, M. G.; Ciminale, V.; Felber, B. K.; Pavlakis, G. N.; Bader, J. P. Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action. J. Acquired Immune Defic. Syndr. 1992, 5, 771-781.
44. Brown, P. O.; Bowerman, B.; Varmus, H. E.; Bishop, J. M. Correct integration of retroviral DNA in vitro. Cell 1987, 49, 347-356.
45. Ellison, V.; Abrams, H.; Roe, T.; Lifson, J.; Brown, P. Human immunodeficiency virus integration in a cell-free system. J. Virol. 1990, 64, 2711-2715.
46. Katayanagi, K.; Miyagawa, M.; Matsushima, M.; Ishikawa, M.; Kanaya, S.; Ikehara, M.; Matsuzaki, T.; Morikawa, K. Three-dimensional structure of ribonuclease H from E. coli. Nature 1990, 347, 306-309.
47. Katayanagi, K.; Miyagawa, M.; Matsushima, M.; Ishikawa, M.; Kanaya, S.; Nakamura, H.; Ikehara, M.; Matsuzaki, T.; Morikawa, K. Structural details of ribonuclease H from Escherichia coli as refined to an atomic resolution. J. Mol. Biol. 1992, 223, 1029-1052.
48. Davies, J. F.; Hostomska, Z.; Hostomsky, Z.; Jordan, S. R.; Matthews, D. A. Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science 1991, 252, 88-95.
49. Vink, C.; Lutzke, R. A.; Plasterk, R. H. A. Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA. Nucleic Acids Res. 1994, 22, 4103-4110.
50. Foltin, S. K.; Holler, T. P.; Hupe, D. J. The DNA processing activity of HIV-1 integrase with magnesium as metal cofactor. FASEB J. 1995, 9, A1398.
51. (2+)-dependent 3′-processing activity for human immunodeficiency virus type 1 integrase in vitro: real-time kinetic studies using fluorescence resonance energy transfer. Biochemistry 1995, 34, 10205-10214.
52. Lee, S. P.; Censullo, M. L.; Kim, H. G.; Han, M. K. Substrate-length-dependent activities of human immunodeficiency virus type 1 integrase in vitro: differential DNA binding affinities associated with different lengths of substrates. Biochemistry 1995, 34, 10215-10223.
53. Engelman, A.; Craigie, R. Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J. Virol. 1995, 69, 5908-5911.
54. Pemberton, I. K.; Buckle, M.; Buc, H. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II). J. Biol. Chem. 1996, 271, 1498-1506.
55. Raghavan, K.; Buolamwini, J. K.; Fesen, M. R.; Pommier, Y.; Kohn, K. W.; Weinstein, J. N. Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study. J. Med. Chem. 1995, 38, 890-897.
56. Perutz, M. F. The role of aromatic rings as hydrogen-bond acceptors in molecular recognition. Phil. Trans. R. Soc. A 1993, 345, 105-112.
57. Dougherty, D. A. Cation-π interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 1996, 271, 163-168.
58. Sonner, J.; Nishizawa, K.; Kebarle, P. Ion-Solvent Molecule Interactions in the Gas Phase. The Potassium Ion and Benzene. J. Phys. Chem. 1981, 85, 1814-1820.
59. Taft, R. W.; Anvia, F.; Gal, J.-F.; Walsh, S.; Capon, M.; Holmes, M. C.; Hosn, K.; Oloumi, G.; Vasanwala, R.; Yazdani, S. Free energies of cation-molecule complex formation and of cation-solvent transfers. Pure Appl. Chem. 1990, 62, 17-23.
60. Guo, B. C.; Purnell, J. W.; Castleman, A. W., Jr. The Clustering Reactions of Benzene with Sodium and Lead Ions. Chem. Phys. Lett. 1990, 168, 155-160.
61. Kumpf, R. A.; Dougherty, D. A. A mechanism for ion selectivity in potassium channels: computational studies of cation-p interactions. Science 1993, 261, 1708-1710.
62. Caldwell, J. W.; Kollman, P. A. Cation-p Interactions: Nonadditive Effects Are Critical in Their Accurate Representation. J. Am. Chem. Soc. 1995, 117, 4177-4178.
63. CRC Handbook of Chemistry and Physics, 74th ed.; CRC Press, Inc.: Boca Raton, Ann Arbor, London, Tokyo, 1993; pp 12-8-12-9.
64. Cody, V. Mechanisms of Molecular Recognition: Crystallographic Evidence for Multiple Inhibitor Binding Modes in Two Protein Classes. Abstract Book of the 12th Annual Conference of the Molecular Graphics Society, Interlaken, Switzerland, June 7-11, 1993; Abstract P087.
65. Schulze-Gahmen, U.; Brandsen, J.; Jones, H. D.; Morgan, D. O.; Meijer, L.; Vesely, J.; Kim, S. H. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine. Proteins 1995, 22, 378-391.
66. Wang, S.; Kazanietz, M. G.; Blumberg, P. M.; Marquez, V. E.; Milne, G. W. A. Molecular Modeling and Site-Directed Mutagenesis Studies of a Phorbol Ester Binding Site in Protein Kinase C. J. Med. Chem. 1996, 39, 2541-2553.
67. Jenkins, T. M.; Engelman, A.; Ghirlando, R.; Craigie, R. A Soluble Active Mutant of HIV-1 Integrase-Involvement of Both the Core and Carboxyl-Terminal Domains in Multimerization. J. Biol. Chem. 1996, 271, 7712-7718.